NG Industries Ltd.

NG Industries Ltd.

BBSE:NGIND
100.05
INR
-1.05
(-1.04%)
5.76EPS
19.78P/E
381.96MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
41.18
44.37
50.53
51.58
51.82
52.73
55.22
35.47
54.98
55.82
50.39
49.39
48.93
50.53
Basic EPS, GAAP
4.53
4.27
4.57
4.24
4.2
3.36
4.38
1.83
7.79
24.82
15.02
23.1
5.17
5.76
Free Cash Flow per Basic Share
4.55
4.43
4.91
3.72
7.25
11.41
6.53
2.3
-7.52
8.94
-6.17
3.43
2.6
- -
Dividend per Share
3.55
3.51
3.48
4.22
4.21
4.22
4.23
0.03
0.02
3.5
3.5
3.5
3.49
- -
Book Value per Share
42.74
42.81
39.18
36.76
35.36
32.75
27.87
44.79
71.37
84.17
107.85
114.96
100.17
- -
Tangible Book Value per Share
42.74
42.81
39.18
36.76
35.36
32.58
27.78
44.73
71.33
84.16
107.84
114.95
100.16
- -
Basic Weighted Avg Shares
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Sales/Revenue/Turnover
138
149
169
173
174
177
185
119
184
187
169
165
164
169
Operating Margin (%)
13.11
9.93
15.4
13.38
14.12
12.73
12.07
6.45
9.7
7.27
8.43
7.65
7.52
7.76
Depreciation Expense
9
12
6
6
6
6
6
5
6
5
6
6
6
6
Net Income, GAAP
15
14
15
14
14
11
15
6
26
83
50
77
17
19
Effective Tax Rate (%)
27.33
26.98
36.62
36.1
34.21
34.97
27.67
26.28
21.38
13.82
14.01
15.34
19.22
18.91
Profit Margin (%)
11.01
9.61
9.04
8.21
8.11
6.37
7.93
5.17
14.16
44.46
29.82
46.77
10.58
11.4
Working Capital
-5
-5
8
6
- -
5
-23
6
19
5
12
9
10
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
143
143
131
123
118
110
93
150
239
282
361
385
336
- -
Return on Invested Capital (%)
7.53
6.8
9.8
10.35
11.65
11.37
13.07
4.07
6.77
4.24
3.55
2.62
2.61
- -
Return on Capital (%)
9.9
9.25
10.34
10
10.25
9.32
12.46
4.55
13.21
31.32
15.27
20.06
4.75
- -
Return on Common Equity (%)
10.66
9.97
11.15
11.16
11.65
9.86
14.44
5.04
13.41
31.91
15.65
20.73
4.81
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
16
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
502
428
382

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
29
- -
Cash, Cash Equivalents & STI
- -
14
- -
Accounts Receivable, Net
- -
5
- -
Inventories
- -
8
- -
Total Current Liabilities
- -
19
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
16
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.76%
19.83%
-12.87%
Free Cash Flow
-97.36%
-198.82%
-24.35%
Net Income, GAAP
42.44%
96.09%
-77.6%
Sales/Revenue/Turnover
1.72%
8.78%
-0.92%
Total Cash Common Dividend
2,154.5%
4,324.59%
-0.11%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
37
44
40
45
165
2026
37
40
43
44
164
2027
42
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.48
8.85
20.03
-7.26
23.1
2026
0.58
1.28
1.27
2.05
5.17
2027
1.16
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
3.5
2026
- -
- -
- -
- -
3.49
2027
- -
- -
- -
- -
- -

Company Description

CEO
Tilak Raj Nagar
Full Time Employees
64
Sector
Health services
Industry
Hospital/Nursing management
Address
37A, Dr. Meghnad Saha Sarani Kolkata WB India 700029
IPO Date
Jun 5, 1995
Website
ngind.com
Business
N G Industries Ltd N G Industries Ltd (NGIND.BO) operates as a healthcare delivery organization in India, offering diagnostic centers with daycare and nursing home facilities providing pathology, radiology, cardiology, gastroenterology, infertility treatments, minimal invasive surgeries, general surgery, joint replacements, urology, and preventive healthcare services; multispecialty clinics; inpatient and outpatient care through its 53-bedded N G Nursing Home including an intensive care unit; and retail pharmacy dispensing via two N G Pharmacy outlets in South Kolkata. The company, founded in 1994 and headquartered at 1st Floor, 37A, Dr Meghnad Saha Sarani, Kolkata, West Bengal, focuses on the hospitals and medical services industry, serving patients primarily in the South Kolkata region with no reported subsidiaries or parent relationships. Recent financial performance for the year ended March 2025 shows net profit rising 53.88% to Rs 7.74 crore amid a 1.95% sales decline to Rs 16.55 crore, alongside board disclosures on management changes and related party transactions for the half-year ended March 2024, with a forthcoming board meeting scheduled for November 8, 2025, to consider unannounced matters.